Treating Gonarthritis with 3 Therapeutic Regimens: Cost-effectiveness Analysis / 中国药房

ABSTRACT

OBJECTIVE: To evaluate the therapeutic effects and cost-effectiveness of 3 therapeutic regimens in the treatment of gonarthritis. METHODS: The cost-effectiveness analyses were conducted among 3 therapeutic regimens regimen A(sodium hyaluronate), regimen B(sodium hyaluronate plus compound betamethasone) and regimen C(sodium hyaluron_ate plus triamcinolone acetonide acetate). RESULTS: The total costs for Group A, B and C were 956.5 yuan, 1 206 yuan and 998.5 yuan, respectively. The effective rates were 79.2%, 91.3% and 96.4%, respectively. The cost-effectiveness ratios were 12.08, 13.21 and 10.36 respectively. As compared with regimen A, the incremental cost-effectiveness ratios for regimen B and C were 20.62 and 2.44 respectively. CONCLUSION: Regimen C is more preferable among the three therapeutic regimens.